Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 6578

By Susan Ip-Jewell## **Space Medicine, Health and MedTech Innovations, a lecture by Susan Ip-Jewell**

In the frame of the new Space Renaissance Academy Webinar Series programme, chaired by the optimum Sabine Heinz, a quite interesting and rich lecture was given yesterday by Dr. Susan Ip Jewell.

Susan is CEO and founder of Mars Moon Astronautic Academy Research Science (MMAARS), one of the SRI VicePresidents and a pasionate space activist. And she’s Commander of Analog Training missions on Moon and Mars simulated surface.

In her lecture, she gives us a wide overlook on many aspects of human health in space, the edge of the space medicine, the innovative techniques using incremental technologies, developing systems integrating robotic, artificial intelligence, remote telemedicine, avatars and drones.

Continue reading “Space Medicine, Health and MedTech Innovations, a lecture” | >

Quick vid and a reminder of the 4th conference of Lifespan.io is this weekend.

Gene editing can make stem cells invisible to the immune system, making it possible to carry out cell therapy transplants without suppressing the patients’ immune response. Scientists in the US and Germany used immune engineering to develop universal cell products that could be used in all transplant patients. The idea is to create stem cells that evade the immune system; these hypoimmune stem cells are then used to generate cells of the desired type that can be transplanted into any patient without the need for immunosuppression, since the cells won’t elicit an immune response. They used CRISPR-Cas9 to knock out two genes involved in the major histocompatibility complex, which is used for self/non-self discrimination. They also increased the expression of a protein that acts as a “don’t eat me” signal to protect cells from macrophages. Together, these changes made the stem cells look less foreign and avoid clearance by macrophages. The team then differentiated endothelial cells and cardiomyocytes from the engineered stem cells, and they used these to treat three different diseases in mice. Cell therapy treatments using the hypoimmune cells were effective in rescuing hindlimbs from vascular blockage, preventing lung damage in an engineered mouse model, and maintaining heart function following a myocardial infarction. Immunosuppression poses obvious risks to a patient, and generating custom cells for transplant therapy is often prohibitively expensive. The development of universal donor cells that can be used as therapeutics could bring the cost down significantly, making cellular therapeutics available to many more patients in a much safer way.

SOURCES AND FURTHER READING

Continue reading “CRISPR Development Makes Stem Cells “Invisible” to Immune System Without Immunosuppressants” | >

There’s a lot that scientists still don’t understand about pterosaurs, CNET reports, especially because so few fossils have been found. But uncovering this new fossil helps explain how the admittedly terrifying creature lived, hunted, and flourished millions of years ago.

The fossil — a massive jawbone — suggests that the Thapunngaka shawi was a ferocious hunter. The 3.2 foot-long jaw likely held as many as 40 huge, sharp teeth. The creature had a wingspan of 22 feet and a neck longer than a giraffe’s that it used to balance its humongous head, according to CNET.

“This thing would have been quite savage,” study coauthor and University of Queensland School of Biological Sciences PhD student Tim Richards told the site. “It would have cast a great shadow over some quivering little dinosaur that wouldn’t have heard it until it was too late.”

Read more | >

Jeff Bezos’s Blue Origin is challenging a U.S. government contract with Elon Musk’s SpaceX to develop technology to land people on the moon again.

In a complaint filed Friday in the Court of Federal Claims in Washington, Blue Origin said the National Aeronautics and Space Administration’s evaluation process was “unlawful and improper.” The complaint was filed under seal but tandem documents seeking a protective order gave an indication of its contents.

NASA selected SpaceX’s human lander bid on April 16 leading Blue Origin and a bidding partner, Dynetics Inc., to file protests with the Government Accountability Office less than two weeks later alleging that the award process was flawed. The GAO denied that protest on July 30 saying that NASA’s SpaceX selection had been made properly. Blue Origin, which has offered to contribute more than $2 billion of work on the project at no cost to the government, had vowed to continue pursuing the matter.

Read more | >

Summary: Opioid use disorder affects genes associated with proinflammatory immune molecule encoding and genes associated with remodeling the extracellular matrix, suggesting the connection between neurons may be altered as a result of opioid use. Additionally, those with OUD have higher levels of microglia in the brain.

Source: Elsevier.

The epidemic of opioid abuse affects millions of people worldwide, but researchers know surprisingly little about the molecular changes caused by opioids in the human brain.

Read more | >